Structural Formula Procainamide Hydrochloride (Procainamide 01)
Procainamide Hydrochloride Injection, Solution
Product Images NDC 0409-1902
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Procainamide Hydrochloride (NDC 0409-1902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Procainamide 02)
Principal Display Panel (10 mL Vial Label)
This is a description of Procainamide HCl Injection, which has a concentration of 1 gram/10 mL (100 mg/mL). Each mL of the injection contains 100 mg of procainamide HCI, 1 mg methylparaben used as preservative, and 0.8 mg of sodium metabisulfite. HCI and/or NaOH may be present for pH adjustment. The injection should not be used if it appears darker than slightly yellow or any other color. The product contains Metabisulfites and was manufactured by Hospira, Inc. The lot number and expiration date are specified.*
Principal Display Panel (10 mL Vial Carton)
This is a label of a medication called "PROCAINAMIDE HYDROCHLORIDE Injection, USP". Each mL of the injection contains 100 mg of procainamide hydrochloride, as well as methylparaben and sodium metabisulfite as preservatives. It may contain hydrochloric acid and/or sodium hydroxide to adjust the pH. The dosage instructions and precautions are not available due to incomplete information. The label warns that the injection contains metabisulfites.*
Principal Display Panel (2 mL Vial Label)
This is a description of a medication called "Procainamide HCI Injection, USP" with a concentration of 1 gram/2 mL (500 mg/mL). It is available in a multiple-dose prescription with a total volume of 2 mL and has a national drug code (NDC) of 0409-1903-41. The medication is distributed by Hospira Inc. in Lake Forest, IL, USA. The rest of the text contains some illegible characters and appears to be irrelevant.*
Principal Display Panel (2 mL Vial Carton)
This is a product label for a medicine called procainamide hydrochloride. It is a sterile and nonpyrogenic solution used for injection with a recommended aseptic technique. The solution has 500mg of procainamide hydrochloride and 1mg of methylparaben as a preservative per mL, and also contains sodium metabisulfite and sodium hydroxide for pH adjustment. The product is manufactured by Hospira, located in Lake Forest, IL, USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
